HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Desmoid Tumor

Desmoid Tumor

Desmoid tumors, though rare, present unique challenges in cancer research due to their unpredictable behavior. These tumors, also known as desmoid-type fibromatosis, are noncancerous growths that arise from connective tissue. While they do not metastasize, they can invade nearby tissues and organs, causing significant morbidity. Current research aims to understand the molecular mechanisms driving their growth and develop targeted therapies to control their progression. Treatment typically involves a multidisciplinary approach, including surgery, radiation, and systemic therapies. However, recurrence rates remain high, underscoring the need for innovative treatment strategies. Collaborative efforts between researchers, clinicians, and patients are crucial in advancing our understanding of desmoid tumors and improving patient outcomes.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp